Accurate Navigation Towards Effective Treatment Results
Medical oncology treatment regimes, for patients, are often protracted with multiple rounds of therapy in the hope of finding the one that may finally work. The process is enormously taxing for the patient’s already compromised body. Often the right treatment is found too late. It is also expensive and leads to wasted treatment costs, increased hospitalization, and escalated healthcare costs.
How can the therapy that proves to be successful be administered to the patient the first time around? Cellworks TRI products for Physicians – SingulaTM and VenturaTM provide the solution to this problem.
Analytically Designed Efficacious & Cost-effective Therapies- Cellworks TRI
Cellworks’ goal is to improve patient outcomes and reduce healthcare costs. Cellworks creates biosimulation models of the patient’s cancer cell, and simulates the effect of FDA approved drugs to determine each patient’s Therapy Response Index (TRI), which is a measure of the patient’s responsiveness to a drug.
Cellworks SingulaTM or Standard Care Response informs the clinician whether the patient will respond to the standard care targeted therapy. If not, Cellworks VenturaTM or Ideal combination provides a targeted therapeutic regime that would best suit the patient’s tumor genomic profile.
This approach saves vital time for the patients and significantly lowers treatment costs.
Efficacious Personalized Outcomes
Cellworks provides efficacious personalized therapy recommendations, thereby reducing failure rates. Clinicians receive treatment recommendation involving novel combinations of molecularly targeted agents from across indications that synergize to improve therapeutic options for cancer patients. Treatment recommendations are searched across over 170 FDA-approved drugs and investigational compounds.
Cellworks believes in transparency. Each patient report shows target manipulations identified for synergistic effects, describes causality-based resistance mechanism factors, and predicts multiple levels of cellular physiological interactions with precise molecular and protein-functional level details.
Cellworks’ biosimulation predictions have been validated through cell-line studies, animal studies, human ex vivo experiments, retrospective clinical studies and prospective clinical trials, with biomarker and phenotype trends in lab and clinical settings.
- Participated in more than 50 global scientific collaborations
- Conducted over 3000 prediction validations
- Produced over 90 peer-reviewed papers and abstracts
Engage in Improving Health Care Economics
We are happy to connect payers with physicians, to navigate the right therapy to the right patient at the right time.
Participate in this paradigm shift. Leverage the power of innovation to help improve healthcare economics.